Gilead to take selonsertib into phase 3 in NASH
Allergan, diabetic kidney disease, Gilead, Intercept, NASH, non-alcoholic steatohepatitis, pulmonary arterial hypertension, Shire
0 Comment
But drug flops in two other indications.